Zoetis Inc. Remaining Share Repurchase Authorization
Zoetis Inc. (ZTS) had Remaining Share Repurchase Authorization of $2.00 million as of 2022-06-30, per its 10-Q filed 2022-08-04.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 · last filed 2022-08-04
- 2022-06-30: Stock Repurchase Program, Remaining Authorized Repurchase Amount $2.00M.
- 2022-03-31: Stock Repurchase Program, Remaining Authorized Repurchase Amount $319.00M.
- 2021-09-30: Stock Repurchase Program, Remaining Authorized Repurchase Amount $879.00M.
- 2021-06-30: Stock Repurchase Program, Remaining Authorized Repurchase Amount $1.10B.
| Period end | Stock Repurchase Program, Remaining Authorized Repurchase Amount |
|---|---|
| 2022-06-30 | $2.00M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $319.00M 10-Q · filed 2022-05-05 |
| 2021-09-30 | $879.00M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $1.10B 10-Q · filed 2021-08-05 |
| 2021-03-31 | $1.20B 10-Q · filed 2021-05-06 |
| 2020-09-30 | $1.40B 10-Q · filed 2020-11-05 |
| 2020-06-30 | $1.40B 10-Q · filed 2020-08-06 |
| 2020-03-31 | $1.40B 10-Q · filed 2020-05-06 |
| 2019-09-30 | $1.90B 10-Q · filed 2019-11-07 |
| 2019-06-30 | $1.00M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $151.00M 10-Q · filed 2019-05-02 |
| 2018-09-30 | $451.00M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $595.00M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $810.00M 10-Q · filed 2018-05-02 |
| 2017-10-01 | $1.10B 10-Q · filed 2017-11-02 |
| 2017-07-02 | $1.30B 10-Q · filed 2017-08-08 |
| 2017-04-02 | $1.40B 10-Q · filed 2017-05-04 |
| 2016-10-02 | $75.00M 10-Q · filed 2016-11-03 |
| 2016-07-03 | $150.00M 10-Q · filed 2016-08-05 |
| 2016-04-03 | $225.00M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $301.00M 10-K · filed 2016-02-24 |
| 2015-09-27 | $352.00M 10-Q · filed 2015-11-05 |
| 2015-06-28 | $402.00M 10-Q · filed 2015-08-06 |
| 2015-03-29 | $453.00M 10-Q · filed 2015-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |